This topic contains a solution. Click here to go to the answer

Author Question: The brightest stars in a young open cluster will be: A) massive blue stars at the top left on the ... (Read 82 times)

yoroshambo

  • Hero Member
  • *****
  • Posts: 566
The brightest stars in a young open cluster will be:
 
  A) massive blue stars at the top left on the H-R diagram.
  B) red T-tauri stars still heading for the main sequence.
  C) red giants that are fusing helium into carbon.
  D) yellow giants like our Sun, but much larger.
  E) the core stars of planetary nebulae.

Question 2

M-87, the giant elliptical at the heart of the Virgo Supercluster, shows a(n) ________ extending outward from its core, moving at relativistic velocities.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

skipfourms123

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

A

Answer to Question 2

jet





 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library